, , ,

Human mesenchymal stem cells treatment for severe COVID-19:1-year follow-up results of a randomized,double-blind, placebo-controlled trial

|

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除